Cargando…

Daptomycin Population Pharmacokinetics in Patients Affected by Severe Gram-Positive Infections: An Update

Daptomycin pharmacokinetics may not depend on renal function only and it significantly differs between healthy volunteers and severely ill patients. Herein, we propose a population pharmacokinetics model based on 424 plasma daptomycin concentrations collected from 156 patients affected by severe Gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Balice, Giuseppe, Passino, Claudio, Bongiorni, Maria Grazia, Segreti, Luca, Russo, Alessandro, Lastella, Marianna, Luci, Giacomo, Falcone, Marco, Di Paolo, Antonello
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311615/ https://www.ncbi.nlm.nih.gov/pubmed/35884168 http://dx.doi.org/10.3390/antibiotics11070914

Ejemplares similares

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
por: Luci, Giacomo, et al.
Publicado: (2021)

Daptomycin for the Treatment of Gram-Positive Periprosthetic Hip Infections: Can Daptomycin Prevent the Implant Removal?
por: Oe, Kenichi, et al.
Publicado: (2021)

Influence of the type of pathogen on the clinical course of infectious complications related to cardiac implantable electronic devices
por: Polewczyk, Anna, et al.
Publicado: (2021)

Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
por: Tacca, Mario Del, et al.
Publicado: (2013)

Pharmacokinetics and skin-tissue penetration of daptomycin in rats
por: Matsumoto, Kazuaki, et al.
Publicado: (2015)

Daptomycin: a novel lipopeptide antibiotic against Gram-positive pathogens
por: Beiras-Fernandez, Andres, et al.
Publicado: (2010)

Clinical Experience with Daptomycin for the Treatment of Gram-positive Infections in Children and Adolescents
por: Syriopoulou, Vassiliki, et al.
Publicado: (2016)

Daptomycin for the treatment of major gram-positive infections after cardiac surgery
por: Kornberger, A., et al.
Publicado: (2016)

Retrieval of a transcatheter pacemaker in sheep after a mid-term implantation time
por: Bongiorni, Maria Grazia, et al.
Publicado: (2015)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Spontaneous Bacterial Peritonitis Due to Methicillin-Resistant Staphylococcus Aureus in a Patient with Cirrhosis: The Potential Role for Daptomycin and Review of the Literature
por: Falcone, Marco, et al.
Publicado: (2015)

Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2016)

Treatment of gram-positive deep sternal wound infections in cardiac surgery -experiences with daptomycin-
por: Popov, Aron F, et al.
Publicado: (2011)

Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics
por: Hines, Kelly M., et al.
Publicado: (2017)

Brazilian experience in EU-CORE: daptomycin registry and treatment of serious Gram-positive infections
por: Timerman, Artur, et al.
Publicado: (2013)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Daptomycin in treatment of Methicillin-resistant Staphylococcus aureus diskitis
por: Parlato, Ciro, et al.
Publicado: (2011)

Population pharmacokinetics of daptomycin in adult patients undergoing continuous renal replacement therapy
por: Xu, Xiaoying, et al.
Publicado: (2016)

Population Pharmacokinetic/Pharmacodynamic Modelling of Daptomycin for Schedule Optimization in Patients with Renal Impairment
por: García-Martínez, Teresa, et al.
Publicado: (2022)

Population Pharmacokinetics of Intravenous Acyclovir in Oncologic Pediatric Patients
por: Maximova, Natalia, et al.
Publicado: (2022)

Genomic and Long-Term Transcriptomic Imprints Related to the Daptomycin Mechanism of Action Occurring in Daptomycin- and Methicillin-Resistant Staphylococcus aureus Under Daptomycin Exposure
por: Cafiso, Viviana, et al.
Publicado: (2020)

Daptomycin therapy for Gram-positive bacterial infections: a retrospective study of 30 cardiac surgery patients
por: Douka, E, et al.
Publicado: (2008)

Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry
por: Keil, Felix, et al.
Publicado: (2015)

Should High-dose Daptomycin be an Alternative Treatment Regimen for Enterococcal Endocarditis?
por: Peghin, Maddalena, et al.
Publicado: (2019)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
por: Ye, Lingling, et al.
Publicado: (2022)

Midterm results after treatment of gram-positive deep sternal wound infections with daptomycin for cardiac surgery patients
por: Ort, Katharina R, et al.
Publicado: (2013)

Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction
por: Russo, Vincenzo, et al.
Publicado: (2021)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin
por: Jiang, Jhih-Hang, et al.
Publicado: (2015)

Chemoenzymatic synthesis of daptomycin analogs active against daptomycin-resistant strains
por: Scull, Erin M., et al.
Publicado: (2020)

Daptomycin Pharmacokinetics in Blood and Wound Fluid in Critical Ill Patients with Left Ventricle Assist Devices
por: Calov, Stefanie, et al.
Publicado: (2023)

2554. What’s Weight Got to Do with It? Prospective Pharmacokinetic/Pharmacodynamic Evaluation of Fixed-Dose Daptomycin
por: Olney, Katie B, et al.
Publicado: (2023)

973. Pharmacokinetic/Pharmacodynamic Evaluation and Dose Optimization of Daptomycin in Pediatric Patients with Staphylococcus aureus Bacteremia
por: Olney, Katie B, et al.
Publicado: (2023)

Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients
por: Lai, Chung-Chih, et al.
Publicado: (2013)

Dermabacter hominis: a usually daptomycin-resistant gram-positive organism infrequently isolated from human clinical samples
por: Fernández-Natal, I, et al.
Publicado: (2013)

Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry
por: Gonzalez-Ruiz, Armando, et al.
Publicado: (2015)

Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads
por: Bongiorni, Maria Grazia, et al.
Publicado: (2008)

Efficacy of Daptomycin-Containing Regimen for Treatment of Staphylococcal or Enterococcal Vertebral Osteomyelitis: A Prospective Clinical Experience
por: Russo, Alessandro, et al.
Publicado: (2020)

Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review
por: Hodiamont, Caspar J., et al.
Publicado: (2022)

Transvenous Lead Extraction in Patients with Cardiac Implantable Device: The Impact of Systemic and Local Infection on Clinical Outcomes—An ESC-EHRA ELECTRa (European Lead Extraction Controlled) Registry Substudy
por: Diemberger, Igor, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0v2bhmocqlcgj7gbtk6896demq